CAS NO: | 2227366-51-8 |
生物活性 | Dalbavancin hydrochloride (MDL-63397 hydrochloride) is a semisynthetic lipoglycopeptideantibioticwith potent bactericidal activity againstGram-positive bacteria. Dalbavancin hydrochloride inhibitsStaphylococcus aureusandBacillus anthraciswith MIC90s of 0.06 μg/mL and 0.25 μg/mL, respectively[1][2]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | Dalbavancin is a parenterally administered semisynthetic lipoglycopeptide developed to combat infections caused by resistant gram-positive pathogens. Dalbavancin exhibits potent in vitro bactericidal activity against gram-positive pathogens includingS. aureus(MRSA), VISA, and non-VanA strains of VRE. Dalbavancin is developed for the treatment of complicated skin and skin structure infections (cSSSIs), predominantly those caused by MRSA andβ-hemolytic streptococci, organisms against which it has shown greater potency than existing glycopeptide therapeutic agents[1][2]. | ||||||||||||||||
体内研究 (In Vivo) | Dalbavancin (15-240 mg/kg; intraperitoneal injection; every 36 h or 72 h; for 14 days; female BALB/c mice) treatment has a survival rate of 80% to 100% of mice with all dose regimens[1].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 1853.15 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C88H101Cl3N10O28 | ||||||||||||||||
CAS 号 | 2227366-51-8 | ||||||||||||||||
中文名称 | 盐酸达巴万星;盐酸道古霉素 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 250 mg/mL(134.91 mM;Need ultrasonic) H2O : 50 mg/mL(26.98 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |